Related Experiment Video
Updated: Nov 19, 2025
05:36
Subjective Refraction Test Using a Smartphone for Vision Screening
Published on: October 18, 2024
1.3K
A novel EyePhone© App for improving adherence to glaucoma therapy.
Ari Leshno1,2, Dan Gaton3,4,5, Reut Singer6,3
1The Sam Rothberg Glaucoma Center, Goldschleger Eye Institute, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel. arileshno@gmail.com.
Summary
The EyePhone© App significantly improved medication adherence and quality of life in glaucoma patients. This free reminder tool demonstrated a notable increase in adherence rates and patient well-being after one month.
Area of Science:
- Ophthalmology
- Digital Health
- Patient Adherence Research
Background:
- Glaucoma treatment adherence is critically low despite available therapies.
- Poor adherence negatively impacts patient outcomes and quality of life.
- Novel digital health solutions are needed to support glaucoma management.
Purpose of the Study:
- To evaluate the effectiveness of the EyePhone© App in enhancing medication adherence among glaucoma patients.
- To assess the impact of the app on patients' quality of life.
- To determine if the app can improve intraocular pressure (IOP) control.
Main Methods:
- Prospective, multicenter interventional study involving 133 glaucoma patients.
- Utilized the EyePhone© App for medication reminders on patients' smartphones.
- Assessed adherence using the Morisky Medication Adherence Scale (MMAS-8) and quality of life with the GlauQOL-17 at baseline and 1-month follow-up.
Main Results:
- Highly adherent patients increased from 29.3% to 42.1% (P < 0.001).
- Poorly adherent patients decreased from 29.3% to 20.3% (P = 0.012).
- Quality of life scores significantly improved (P < 0.05), with a trend towards reduced IOP (0.92 mmHg, P = 0.069).
Conclusions:
- The EyePhone© App is an effective tool for improving medication adherence in glaucoma patients.
- The app demonstrated a positive impact on patient quality of life.
- Digital reminder applications show promise in managing chronic eye conditions like glaucoma.
Related Concept Videos
01:27Open Angle Glaucoma: Treatment
823
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
823
01:28Angle Closure Glaucoma: Treatment
952
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
952
01:25Glaucoma: Overview
1.1K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.1K